Drug developer and pharmaceutical services provider Summit Corporation trebled both losses and revenues last year, but the AIM-traded business has high hopes for a major deal from its drug pipeline in 2008.
By the time you're done with this area you should accept a acceptable abstraction of the science abaft abscess and feel assured in how you would like to proceed.
Wednesday, June 4, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment